Cargando…
Effects of Secretome from Fat Tissues on Ion Currents of Cardiomyocyte Modulated by Sodium-Glucose Transporter 2 Inhibitor
Sodium-glucose transporter 2 (SGLT2) inhibitors were shown to decrease mortality from cardiovascular diseases in the EMPA-REG trial. However, the effects of empagliflozin (EMPA) for cardiac arrhythmia are not yet clarified. A total of 20 C57BL/6J mice were divided into four groups: (1) The control g...
Autores principales: | Jhuo, Shih-Jie, Liu, I-Hsin, Tsai, Wei-Chung, Chou, Te-Wu, Lin, Yi-Hsiung, Wu, Bin-Nan, Lee, Kun-Tai, Lai, Wen-Ter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465695/ https://www.ncbi.nlm.nih.gov/pubmed/32784369 http://dx.doi.org/10.3390/molecules25163606 |
Ejemplares similares
-
Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Ameliorate Metabolic Disorder and Obesity Induced Cardiomyocyte Injury and Mitochondrial Remodeling
por: Jhuo, Shih-Jie, et al.
Publicado: (2023) -
Effects of Trans, Trans-2,4-decadienal on the Ions Currents of Cardiomyocytes: Possible Mechanisms of Arrhythmogenesis Induced by Cooking-oil Fumes
por: Jhuo, Shih-Jie, et al.
Publicado: (2020) -
Characteristics of Ventricular Electrophysiological Substrates in Metabolic Mice Treated with Empagliflozin
por: Jhuo, Shih-Jie, et al.
Publicado: (2021) -
Clinical Observation of SGLT2 Inhibitor Therapy for Cardiac Arrhythmia and Related Cardiovascular Disease in Diabetic Patients with Controlled Hypertension
por: Jhuo, Shih-Jie, et al.
Publicado: (2022) -
The right ventricular fibroblast secretome drives cardiomyocyte dedifferentiation
por: Bruns, Danielle R., et al.
Publicado: (2019)